[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"LLC UkrMedGroup\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100595628",false,"NCT07034924","Temporary Aortic Compression With the Abdominal Tourniquet for Refractory Postpartum Hemorrhage","ACT-PPH","Inclusion Criteria:\n\n* Age ≥18 years\n* Clinical diagnosis of postpartum hemorrhage (PPH) refractory to uterotonics and intrauterine balloon tamponade\n* Estimated blood loss greater than 1300 mL\n* Oral informed consent provided prior to device application\n\nExclusion Criteria:\n\n* Patients with postpartum bleeding as a result of trauma, retained placenta or coagulopathy were excluded","FEMALE","18 Years","50 Years",{"count":19,"type":20},20,"ESTIMATED","INTERVENTIONAL",[23],"NA","This multicenter study aims to evaluate effectiveness and safety of using the AAJT-S device as a temporary intervention for severe, atony-related PPH that is refractory to standard therapies",[26],"Postpartum Hemorrhage",[28],"postpartum hemorrhage","RECRUITING","2025-10-02",{"date":32,"type":33},"2025-10-07","ACTUAL",{"date":35,"type":33},"2025-07-01",{"date":37,"type":20},"2026-07",{"name":39,"class":40},"LLC UkrMedGroup","INDUSTRY",""]